⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

HIMS

Hims & Hers Health, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

27.71USD

-1.4200 (-4.87%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on HIMS.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 27.71
P/E—
Dvd Ind Yld0.0%
P/B19.95
P/S2.5
Curr EV/T12M EBITDA-704.6
Mkt Cap (USD)6.5B
Curr EV (USD)7.2B
2)

Per Share Data

EPS T12M-0.63
DPS—
Bk Val Per Sh1.39
Rev/Sh11.12
Cash/Sh3.61
Curr Shares Out224.9M
FCF/Sh0.27
3)

Cash Flow Analysis

P/CF24.5
Curr P/FCF105.0
CF/NI-1.9
Dvd P/O0.0%
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales10.2%
Eff Interest Rate0.0%
4)

Growth Potential

Dil EPS 1Y Gr-3.8%
Cap 1Y Gr13.5%
BPS 1Y Gr4.1%
R&D To Sales—
Retention Rate100.0%
Rev 1Y Gr59.0%
FCF 1Y Gr-71.0%
Assets 1Y Gr204.5%
5)

Profitability

EBITDA-0.1B
EBIT-0.2B
Operating Margin-6.0%
Pretax Margin-6.3%
Net Margin-5.5%
ROA-5.2%
ROE-32.0%
ROC-7.2%
Asset Turnover0.94
6)

Structure

Current Ratio0.93
Quick Ratio0.82
Debt/Assets42.6%
Debt/Com Eq477.1%
Net Debt/EBITDA-13.91
Tot Debt/Capital82.7%
Gross Margin68.4%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.